持续正压呼吸器市场:现状分析与预测(2022-2030年)

持续气道正压通气 (CPAP) 是气道正压通气的一种形式，其中大于大气压的稳定压力持续施加到人的上呼吸道。CPAP 市场的增长归因于多种因素，例如全球范围内糖尿病、高血压、肥胖、阻塞性睡眠呼吸暂停 (OSA) 和呼吸困难等肺部疾病患病率的上升，需求不断增长。

由于睡眠呼吸暂停病例及相关病症数量的增加，以及患有呼吸系统疾病的老年人口的急剧增加，持续气道正压通气市场预计将以约6.4%的稳定速度增长。此外，全球人口正在迅速老龄化，老年人口呼吸系统疾病患病率的增加是市场增长的一个突出因素。老年人也更容易患慢性阻塞性肺病 (COPD)、哮喘和睡眠呼吸暂停等呼吸系统疾病，这推动了对 CPAP 设备的需求。例如，据报导，2020年有1250万人，即成年人的5.0%，被诊断患有COPD（慢性阻塞性肺病、慢性支气管炎、肺气肿）。

按组件划分，市场分为 CPAP 面罩、CPAP 加湿器等。其中，CPAP加湿器品类在2021年市场占据主导地位。CPAP 加湿器是 CPAP 机器的重要配件，正在推动 CPAP 设备市场的增长。睡眠呼吸暂停和其他呼吸系统疾病的患病率不断增加，人们对 CPAP 治疗益处的认识不断提高，以及负担得起的便携式 CPAP 设备的可用性不断增加，这些都是推动市场增长的一些主要因素。

按应用，市场分为睡眠呼吸暂停综合征和慢性阻塞性肺病。其中，由于老年人群中阻塞性睡眠呼吸暂停 (OSA) 病例的增加以及对 OSA 或其他呼吸系统疾病的认识的提高，睡眠呼吸暂停类别将在 2022 年占据市场主导地位，预计将在预测期内推动市场增长。例如，根据欧洲呼吸学会公布的数据，欧洲约有13.0%至32.0%的老年人口患有睡眠呼吸暂停。

根据最终用户，市场分为医院和诊所、家庭护理等。其中，家庭护理类别在 2022 年占据市场主导地位。这主要是因为市场参与者正在专注于推出可供接受疾病治疗的人在家中使用的新型便携式设备。人们越来越倾向于在家中进行 OSA 治疗，尤其是在美国、英国、德国和日本等国家，这推动了家庭护理和其他环境中对这些设备的需求。

为了更好地了解持续气道正压通气行业的市场采用情况，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、意大利、欧洲其他地区） 、亚太地区（中国、日本、印度和亚太地区其他地区）和世界其他国家根据其全球影响力进行分析。由于其完善的医疗基础设施和高科技的采用，预计北美在预测期内将主导全球 CPAP 设备市场。此外，该国睡眠呼吸暂停综合症的负担正在增加，这推动了 CPAP 设备市场的增长。例如，睡眠呼吸暂停组织估计有 2200 万美国人患有睡眠呼吸暂停，并且 80%?? 的中度和重度阻塞性睡眠呼吸暂停未被诊断出来。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制事项

第2章 调查手法或前提

• 调查流程
• 调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对持续正压呼吸器市场带来的影响

第6章 持续正压呼吸器市场收益，2020-2030年

第7章 市场洞察:各零件

• CPAP面罩
• CPAP加湿器
• 其他

第8章 市场洞察:各用途

• 睡眠呼吸中止症
• COPD

第9章 市场洞察:各终端用户

• 医院和诊所
• 居家护理
• 其他

第10章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 全球其他地区

第11章 持续正压呼吸器市场动态

• 推动市场要素
• 市场课题
• 影响分析

第12章 持续正压呼吸器市场机会

第13章 持续正压呼吸器市场趋势

第14章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第15章 价值链分析

第16章 价格分析

第17章 策略性洞察能力

第18章 竞争模式

• 竞争情形
  • 波特的五力分析

第19章 企业简介

• BMC
• ResMed
• Fisher & Paykel Healthcare Limited
• Drive DeVilbiss Healthcare
• Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
• Smiths Group plc
• Airing
• Koninklijke Philips N.V.
• Honeywell International Inc.
• Transcend, Inc.

第20章 免责声明

Continuous positive airway pressure (CPAP) is a type of positive airway pressure ventilation in which a steady pressure larger than atmospheric pressure is continuously applied to a person's upper respiratory tract. The growth of the CPAP market is attributed due to several factors such as the rising prevalence of diabetes, high blood pressure, obesity, obstructive sleep apnea (OSA), and pulmonary disorders, such as dyspnea globally, which is to higher demand for CPAP devices. For instance, according to the Centers for Disease Control and Prevention's Behavioral Risk Factors Surveillance System (BFRSS) 2019, the adult obesity percentage in the United States was 42.4%. This was the first time the national average surpassed 40%.

The continuous positive airway pressure market is expected to grow at a steady rate of around 6.4% owing to the increasing number of sleep apnea cases and related conditions and the surging geriatric population with respiratory diseases. Moreover, the global population is aging at a rapid pace, leading to an increased prevalence of respiratory diseases among the elderly population which is a prominent factor in the growth of the market. Also, older adults are more susceptible to respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea which will drive the demand for CPAP devices. For instance, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema.

Based on component, the market is segmented into CPAP masks, CPAP humidifiers, and others. Among them, the CPAP humidifiers category dominated the market in 2021. CPAP humidifiers are an essential accessory for CPAP machines and are driving the growth of the CPAP devices market. The increasing prevalence of sleep apnea and other respiratory disorders, the growing awareness of the benefits of CPAP therapy, and the increasing availability of affordable and portable CPAP devices are some of the key factors contributing to the market's growth.

Based on application, the market is bifurcated into sleep apnea and COPD. Among them, the sleep apnea category dominated the market in 2022 owing to the growing obstructive sleep apnea (OSA) cases in the geriatric population and the rising awareness for OSA or other respiratory diseases will drive the growth of the market during the forecast period. For instance, according to the data published by the European Respiratory Society, approximately 13.0% to 32.0% of the geriatric population in Europe was suffering from sleep apnea.

Based on end-user, the market is segmented into hospitals & clinics, home care, and others. Among them, the home care category dominated the market in 2022. This is mainly due to the players in the market concentrating on launching new, portable devices that can be used at home among those undergoing treatment for the condition. This, along with a growing preference for treating OSA at home, is driving up demand for these devices in-home care and other settings, particularly in countries like the U.S., the U.K., Germany, and Japan, among others.

For a better understanding of the market adoption of the continuous positive airway pressure industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to dominate the global CPAP devices market during the forecast period due to the presence of well-established healthcare infrastructure and higher adoption of technology in the country. Also, the country is witnessing the growing burden of sleep apnea which in turn is facilitating the CPAP devices market growth. For instance, according to sleep apnea org, It is estimated that 22 million Americans suffer from sleep apnea, with 80 percent of the cases of moderate and severe obstructive sleep apnea undiagnosed.

Some of the major players operating in the market include: BMC; ResMed; Fisher & Paykel Healthcare Limited; Drive DeVilbiss Healthcare; Shanghai Fosun Pharmaceutical Group Co., Ltd.; Smiths Group plc; Airing; Koninklijke Philips N.V.; Honeywell International Inc.; and Transcend, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Continuous Positive Airway Pressure Devices Market
• 2.2. Research Methodology of the Continuous Positive Airway Pressure Devices Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET

6 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY COMPONENT

• 7.1. CPAP Mask
• 7.2. CPAP Humidifier
• 7.3. Others

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Sleep Apnea
• 8.2. COPD

9 MARKET INSIGHTS BY END-USER

• 9.1. Hospitals & Clinics
• 9.2. Home Care
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET OPPORTUNITIES

13 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

• 18.1. Competitive Landscape
  • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

• 19.1. BMC
• 19.2. ResMed
• 19.3. Fisher & Paykel Healthcare Limited
• 19.4. Drive DeVilbiss Healthcare
• 19.5. Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
• 19.6. Smiths Group plc
• 19.7. Airing
• 19.8. Koninklijke Philips N.V.
• 19.9. Honeywell International Inc.
• 19.10. Transcend, Inc.

20 DISCLAIMER